2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
69
Rectal Neoplasms
10
Triple Negative Breast Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Lung Neoplasms
6
Carcinoma, Intraductal, Noninfiltrating
6
Adenocarcinoma of Lung
6
Breast Carcinoma In Situ
4
Pancreatic Neoplasms
2
Unilateral Breast Neoplasms
1
Transsexualism
1
Solitary Pulmonary Nodule
1
Social Isolation
1
Recurrence
1
Piebaldism
1
Patient Satisfaction
1
Pain, Postoperative
1
Neoplastic Cells, Circulating
1
Neoplasm Micrometastasis
1
Margins of Excision
1
Lymphedema
1
Local Recurrence of Malignant Tumor of Breast
1
Inflammatory Breast Neoplasms
1
Gynecomastia
1
Gastrointestinal Stromal Tumors
1
Colorectal Neoplasms
1
Chordoma
1
Carcinoma, Lobular
1
Carcinoma, Ductal, Breast
1
Carcinoma, Ductal
1
Interventions
Standard of Care
8
Surveys and Questionnaires
7
COVID-19 Vaccines
6
Blood Specimen Collection
6
BNT162 Vaccine
6
Specimen Handling
5
2019-nCoV Vaccine mRNA-1273
5
Hydroxychloroquine
4
Surgical Procedures, Operative
3
Practice Guidelines as Topic
3
tocilizumab
2
sotrovimab
2
sinovac COVID-19 vaccine
2
cilgavimab and tixagevimab drug combination
2
Sodium Chloride
2
Pandemic Preparedness
2
Data Collection
2
CVnCoV COVID-19 vaccine
2
COH04S1 COVID-19 vaccine
2
Azithromycin
2
selinexor
1
remdesivir
1
regorafenib
1
proxalutamide
1
palbociclib
1
ogalvibart
1
monalizumab
1
lenzilumab
1
heterologous prime boost COVID-19 vaccination
1
crexavibart
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
COVID-19
×
Mastectomy, Segmental
×
Clear all
NCT04929964
2021-08-11
COVID-19
Bahria University
Completed
87 enrolled